Repeat sequence of Epstein-Barr virus-encoded nuclear antigen 1 protein interrupts proteasome substrate processing
- PMID: 14688254
- DOI: 10.1074/jbc.M310449200
Repeat sequence of Epstein-Barr virus-encoded nuclear antigen 1 protein interrupts proteasome substrate processing
Abstract
The Epstein-Barr virus thwarts immune surveillance through a Gly-Ala repeat (GAr) within the viral Epstein-Barr virus-encoded nuclear antigen 1 protein. The GAr inhibits proteasome processing, an early step in antigen peptide presentation, but the mechanism of proteasome inhibition has been unclear. By embedding a GAr within ornithine decarboxylase, a natural proteasome substrate that does not require ubiquitin conjugation, we now demonstrate inhibition in a purified system, excluding involvement of ubiquitin conjugation or of proteins extraneous to substrate and proteasome. We show further that the GAr acts as a stop-transfer signal in proteasome substrate processing, resulting in vivo in partial proteolysis that halts just short of the GAr. Similarly, introducing a GAr into green fluorescent protein destabilized by the ornithine decarboxylase degradation domain also stops the progress of proteolysis, leading to the accumulation of partial degradation products. We postulate that the ATP motor of the proteasome slips when it encounters the GAr, impeding further insertion and, in this way, halting degradation.
Similar articles
-
Inhibition of proteasomal degradation by the gly-Ala repeat of Epstein-Barr virus is influenced by the length of the repeat and the strength of the degradation signal.Proc Natl Acad Sci U S A. 2000 Jul 18;97(15):8381-5. doi: 10.1073/pnas.140217397. Proc Natl Acad Sci U S A. 2000. PMID: 10890896 Free PMC article.
-
Inhibition of ubiquitin/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1.Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12616-21. doi: 10.1073/pnas.94.23.12616. Proc Natl Acad Sci U S A. 1997. PMID: 9356498 Free PMC article.
-
Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1.Science. 2003 Sep 5;301(5638):1371-4. doi: 10.1126/science.1088902. Science. 2003. PMID: 12958359
-
Avoiding proteasomal processing: the case of EBNA1.Curr Top Microbiol Immunol. 2002;269:23-36. doi: 10.1007/978-3-642-59421-2_2. Curr Top Microbiol Immunol. 2002. PMID: 12224511 Review.
-
TAP-independent antigen presentation on MHC class I molecules: lessons from Epstein-Barr virus.Microbes Infect. 2003 Apr;5(4):291-9. doi: 10.1016/s1286-4579(03)00031-5. Microbes Infect. 2003. PMID: 12706442 Review.
Cited by
-
Isotypes of Epstein-Barr virus antibodies in rheumatoid arthritis: association with rheumatoid factors and citrulline-dependent antibodies.Biomed Res Int. 2015;2015:472174. doi: 10.1155/2015/472174. Epub 2015 Apr 27. Biomed Res Int. 2015. PMID: 26000294 Free PMC article.
-
The ubiquitin ligase Hul5 promotes proteasomal processivity.Mol Cell Biol. 2010 Feb;30(4):985-94. doi: 10.1128/MCB.00909-09. Epub 2009 Dec 14. Mol Cell Biol. 2010. PMID: 20008553 Free PMC article.
-
The silencing suppressor P25 of Potato virus X interacts with Argonaute1 and mediates its degradation through the proteasome pathway.Mol Plant Pathol. 2010 Sep;11(5):641-9. doi: 10.1111/j.1364-3703.2010.00634.x. Mol Plant Pathol. 2010. PMID: 20696002 Free PMC article.
-
Slippery substrates impair ATP-dependent protease function by slowing unfolding.J Biol Chem. 2014 Feb 7;289(6):3826. doi: 10.1074/jbc.L113.532622. J Biol Chem. 2014. PMID: 24510918 Free PMC article. No abstract available.
-
Allostery Modulates Interactions between Proteasome Core Particles and Regulatory Particles.Biomolecules. 2022 May 30;12(6):764. doi: 10.3390/biom12060764. Biomolecules. 2022. PMID: 35740889 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
